Switch to:
Novo Nordisk A/S (NYSE:NVO)
EV/EBITDA
20.89 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Novo Nordisk A/S's enterprise value is $125,089 Mil. Novo Nordisk A/S's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2015 was $5,988 Mil. Therefore, Novo Nordisk A/S's EV/EBITDA ratio for today is 20.89.

NVO' s EV/EBITDA Range Over the Past 10 Years
Min: 10   Max: 38
Current: 21.2

10
38

During the past 13 years, the highest EV/EBITDA Ratio of Novo Nordisk A/S was 38.00. The lowest was 10.00. And the median was 20.00.

NVO's EV/EBITDA is ranked lower than
56% of the 281 Companies
in the Global Biotechnology industry.

( Industry Median: 18.19 vs. NVO: 21.20 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Novo Nordisk A/S's stock price is $48.90. Novo Nordisk A/S's earnings per share for the trailing twelve months (TTM) ended in Sep. 2015 was $1.94. Therefore, Novo Nordisk A/S's P/E Ratio for today is 25.19.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Novo Nordisk A/S's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=125088.820/5988.11116253
=20.89

Novo Nordisk A/S's current Enterprise Value is $125,089 Mil.
Novo Nordisk A/S's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2015 was 0 (Dec. 2014 ) + 2147.08356296 (Mar. 2015 ) + 1941.46855251 (Jun. 2015 ) + 1899.55904706 (Sep. 2015 ) = $5,988 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Novo Nordisk A/S's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=48.90/1.94100542746
=25.19

Novo Nordisk A/S's share price for today is $48.90.
Novo Nordisk A/S's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2015 was 0.414740435121 (Dec. 2014 ) + 0.549641790179 (Mar. 2015 ) + 0.486006620524 (Jun. 2015 ) + 0.490616581636 (Sep. 2015 ) = $1.94.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 16.2719.0921.1316.2713.5118.6327.3819.0320.4523.14

Novo Nordisk A/S Quarterly Data

Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15
ev2ebitda 16.4219.3820.4525.3224.8525.1823.1427.7424.6422.42
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK